Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rotman

Showing results (161-170 of 182) with videos related to

Pageof 19
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985)M Roach, J Krall, J W Keller, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1980
Patterns of tumor recurrence after definitive irradiation for inoperable non-oat cell carcinoma of the lungC A Perez, K Stanley, P Rubin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1991
Estimates of radiation absorbed dose for intraperitoneally administered iodine-131 radiolabeled B72.3 monoclonal antibody in patients with peritoneal carcinomatosesS M Larson, J A Carrasquillo, D C Colcher, et al.
Calcified Tissue International|October 13, 2017
Illness Perceptions are Associated with Quality of Life in Patients with Fibrous DysplasiaB C J Majoor, C D Andela, C R Quispel, et al.
Cancer|February 15, 1993
Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Results of Radiation Therapy Oncology Group 85-28B E Epstein, C B Scott, W T Sause, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1995
Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13K K Fu, T F Pajak, V A Marcial, et al.
Journal of the National Cancer Institute|May 5, 1993
Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trialsW J Curran, C B Scott, J Horton, et al.
Journal of Neuro-Oncology|March 11, 1992
Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trialsW J Curran, C B Scott, J Horton, et al.
Urology|April 1, 1995
Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology GroupM V Pilepich, J M Krall, M al-Sarraf, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1995
Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomasD J Lee, D Cosmatos, V A Marcial, et al.
Pageof 19

Showing results (161-170 of 182) with videos related to

Sort By:
Pageof 19
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985)M Roach, J Krall, J W Keller, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1980
Patterns of tumor recurrence after definitive irradiation for inoperable non-oat cell carcinoma of the lungC A Perez, K Stanley, P Rubin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1991
Estimates of radiation absorbed dose for intraperitoneally administered iodine-131 radiolabeled B72.3 monoclonal antibody in patients with peritoneal carcinomatosesS M Larson, J A Carrasquillo, D C Colcher, et al.
Calcified Tissue International|October 13, 2017
Illness Perceptions are Associated with Quality of Life in Patients with Fibrous DysplasiaB C J Majoor, C D Andela, C R Quispel, et al.
Cancer|February 15, 1993
Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Results of Radiation Therapy Oncology Group 85-28B E Epstein, C B Scott, W T Sause, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1995
Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13K K Fu, T F Pajak, V A Marcial, et al.
Journal of the National Cancer Institute|May 5, 1993
Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trialsW J Curran, C B Scott, J Horton, et al.
Journal of Neuro-Oncology|March 11, 1992
Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trialsW J Curran, C B Scott, J Horton, et al.
Urology|April 1, 1995
Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology GroupM V Pilepich, J M Krall, M al-Sarraf, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 1995
Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomasD J Lee, D Cosmatos, V A Marcial, et al.
Pageof 19